title: Pattern and chemosensitivity of ovarian cancer in patients with BRCA1/2 mutations.
abstract: Our study adds to the BRCAness theory that hereditary ovarian cancers with BRCA 1 or 2 mutations show better chemosensitivity when compared with sporadic ovarian cancers.
authors.affiliation: Department of Oncology, Ninewells Hospital, Dundee, UK.
authors.forename: K
authors.initials: K
authors.lastname: Ragupathy
authors.forename: M
authors.initials: M
authors.lastname: Ferguson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D008875:Middle Aged; D009154:Mutation; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D017671:Platinum Compounds / Q000627:therapeutic use*; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D017671:Platinum Compounds; D004317:Doxorubicin; D007069:Ifosfamide